An investigational T-cell therapy shows promise against six viral infections common after stem cell transplants
Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and safety in a phase II study of patients who had undergone ...
Jan 11, 2023
0
2